Trial Profile
Treatment of Schizophrenia and Related Disorders in Children and Adolescents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2021
Price :
$35
*
At a glance
- Drugs Molindone (Primary) ; Olanzapine (Primary) ; Risperidone (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms TEOSS
- 01 Jun 2010 Results from the 44-week double-blind extension phase have been published in the Journal of the American Academy of Child & Adolescent Psychiatry.
- 09 Oct 2005 New trial record.